Position history for Avoro Capital Advisors LLC's holdings in ARROWHEAD PHARMACEUTICALS IN
Avoro Capital Advisors LLC holds 10.7M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $670.9M as of 2026-Q1. The position was increased (+0.7% shares). ARWR represents 6.6% of Avoro Capital Advisors LLC's portfolio.
Current Value
$670.9M
Current Shares
10.7M
Total Value Change
+$439.9M
Total Shares Change
+1.8M
Other major holders of ARWR: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, BANQUE PICTET & CIE SA
Increased |
| 10.7M |
+0.7% |
| $670.9M |
| 6.6% |
| $64.10 |
63 |
| 2025-Q4 | Decreased | 10.6M | -2.5% | $705.4M | 6.9% | $67.25 | 0 |
| 2025-Q3 | Increased | 10.9M | +2.8% | $375.9M | 4.9% | $33.78 | 60 |
| 2025-Q2 | Decreased | 10.6M | -4.6% | $167.5M | 2.9% | $16.08 | 0 |
| 2025-Q1 | Unchanged | 11.1M | 0.0% | $141.6M | 2.2% | $13.82 | 0 |
| 2024-Q4 | Increased | 11.1M | +25.0% | $208.9M | 3.0% | $18.61 | 65 |
| 2024-Q3 | Unchanged | 8.9M | 0.0% | $172.2M | 2.5% | $19.67 | 0 |
| 2024-Q2 | Increased | 8.9M | +3.9% | $231M | 3.1% | $25.99 | 60 |